Notch3 drives development and progression of cholangiocarcinoma
- 10 October 2016
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 113 (43) , 12250-12255
Abstract
Significance: Clinical outcomes in cholangiocarcinoma (CC) are poor; few patients are candidates for curative resection, and palliative chemotherapy produces only modest effects on survival. With an increasing incidence, new targets are urgently needed. Notch has been identified as having potential to induce CC when transgenically overexpressed, and this study aimed to characterize how endogenous Notch might drive tumorigenesis. We identify the atypical receptor Notch3 as differentially overactivated in CCs in humans, rats, and mice, with genetic deletion significantly reducing CC growth. Notch3 sustains tumor cell survival through PI3k/Akt activation via a noncanonical mechanism independent of Recombinant Signal Binding Protein for Immunoglobulin Kappa J Region (RBPJ), presenting an opportunity to target the pathway without disrupting classical Notch and bypassing toxicities associated with γ-secretase inhibitors.Keywords
Funding Information
- Wellcome Trust (R52006)
- European Research Council (ERC StG 311301)
- Cancer Research UK (A12481 and A17196)
- Cancer Research UK (A11650)
- Cancer Research UK (R42296)
This publication has 27 references indexed in Scilit:
- Combined targeting of AKT and mTOR using MK‐2206 and RAD001 is synergistic in the treatment of cholangiocarcinomaInternational Journal of Cancer, 2013
- Cholangiocarcinomas can originate from hepatocytes in miceJournal of Clinical Investigation, 2012
- Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase InhibitorsGastroenterology, 2012
- Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver diseaseNature Medicine, 2012
- Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinomaProceedings of the National Academy of Sciences, 2010
- Notch signaling controls liver development by regulating biliary differentiationDevelopment, 2009
- A CK19CreERT knockin mouse line allows for conditional DNA recombination in epithelial cells in multiple endodermal organsGenesis, 2008
- p53 mutations in human cholangiocarcinoma: a reviewLiver International, 2005
- Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cellsNature, 2005
- Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cellsInternational Journal of Cancer, 1992